To describe a case of coincident Castleman’s disease and myasthenia gravis that initially presented as rapidly progressive dysphagia and dysphonia and to review the unique pathophysiology of these two uncommon diagnoses.
Methods:
Case report and literature review.
Results:
Castleman’s disease, angiofollicular or giant lymph node hyperplasia, is a rare benign lymphoid proliferation. Traditionally, the disease is classified based on histologic and clinical characteristics. Fewer than 10 cases with concurrent myasthenia gravis have been reported. Myasthenia gravis and thymic epithelial tumors are both associated with acetylcholine receptor antibody. While patients with isolated Castleman’s disease are usually asymptomatic, those who have concurrent myasthenia gravis and undergo surgical treatment are at increased risk of postoperative myasthenic crisis. Both pre- and postoperative plasmapheresis are suggested to improve muscle strength and prevent severe postoperative complications.
Conclusions:
In the setting of multiple cranial neuropathies including velopalatal insufficiency and bilateral ptosis it is important to consider myasthenia gravis. Castleman’s disease occurs rarely in conjunction with myasthenia gravis but may increase the risk of myasthenic crisis.
FeinASTrejo BittarHEShendeMRScalzettiEMKoMW.Castleman disease presenting with pseudotumour cerebri and myasthenia gravis: a case report and literature review. Neuroophthalmol. 2019;43(3):185-191.
4.
PinheiroVGFFernandesGHCezarLCAlvesNdAMenezesDB. Castleman’s disease accompanied by pleural effusion. J Bras Pneumol. 2008;34(8):626-630.
5.
YehCMChouC-MWongLC.Castleman’s disease mimicking intrapulmonary malignancy. Ann Thorac Surg. 2007; 84(2):e6-e7.
6.
KrawczunGAGarcia CdeMItoKFerreira FilhoOFThomsonJC.Castleman disease or angiofollicular hyperplasia as a solitary pulmonary nodule: case report. J Bras Pneumol. 2007;33(2):226-228.
7.
WestphalFLLimaLCSantanaLCNettoJCAmaralVCSilva MdosS.Castleman’s disease associated with follicular dendritic cell sarcoma and myasthenia gravis. J Bras Pneumol. 2010;36(6):819-823.
8.
TalatNBelgaumkarAPSchulteK-M.Surgery in Castleman’s disease: a systematic review of 404 published cases. Ann Surg. 2012;255(4):677-684.
9.
MendonçaCRiosEReisCSantosASilvaPS.Doença de Castleman-a propósito de um caso clínico. Rev Soc Port Med Interna. 2008;15(4):249-253.
10.
IzumiMMochizukiMKurodaMIwayaKMukaiK.Angiomyoid proliferative lesion: an unusual stroma-rich variant of Castleman’s disease of hyaline-vascular type. Virchows Arch. 2002;441(4):400-405.
11.
OhgamiRSZhaoSOhgamiJK, et al. TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2012;36(11):1619-1628.
12.
NishimotoNSasaiMShimaY, et al. Improvement in Castleman’s disease by humanized anti-interleukin-6 receptor antibody therapy. Blood. 2000;95(1):56-61.
13.
MuhseinKALiewN-CShakerARHShahrinIAW. Localized Castleman’s disease presenting as a vascular right iliac fossa mass. Asian J Surg. 2004;27(1):54-57.
14.
OliveiraCVGonçalvesCEAlmeidaVFOliveiraAMPimentaFC.Doença de Castleman localizada abdominal. Rev Bras Hematol Hemoter. 2005;27(2):133-137.
15.
BowneWBLewisJJFilippaDA, et al. The management of unicentric and multicentric Castleman’s disease: a report of 16 cases and a review of the literature. Cancer. 1999;85(3):706-717.
16.
IshikawaKKatoTAragakiM, et al. A case of Castleman’s disease with myasthenia gravis. Ann Thorac Cardiovasc Surg. 2014;20(suppl):585-588.
17.
DayJRBewDAliMDinaRSmithPL.Castleman’s disease associated with myasthenia gravis. Ann Thorac Surg. 2003;75(5):1648-1650.
18.
AdelmanHMCacciatoreMLPascualJFMikeJMAlbertsWMWallachPM.Castleman disease in association with POEMS. Am J Med Sci. 1994;307(2):112-114.
19.
CaneppeleSPicartNBayle-LebeyP, et al. Paraneoplastic pemphigus associated with Castleman’s tumour: clinical dermatology. Concise report. Clin Exp Dermatol. 2000;25(3):219-221.
20.
Abdel-ReheimFAKossWRappaportESArberDA.Coexistence of Hodgkin’s disease and giant lymph node hyperplasia of the plasma-cell type (Castleman’s disease). Arch Pathol Lab Med. 1996;120(1):91-96.
21.
ChanAChanKChanJAuWHoWNgW.Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman’s disease of the nasopharynx: tracing its evolution by sequential biopsies. Histopathology. 2001;38(6):510-518.
22.
InadaKHamazakiM.Localized mediastinal lymph-node hyperplasia resembling thymoma; a case report. Ann Surg. 1958;147(3):409-413.
23.
BenjaminBZaltzmanRShpitzBGordonCRAvitalS.Presacral mass discovered during pregnancy followed by myasthenia gravis. Isr Med Assoc J. 2015;17(5):318-320.
24.
Dinesha PadyanaMNayakKNirupamaMPaiDS.Castleman’s Disease with Paraneoplastic Pemphigus. Indian J Dermatol. 2014;59(4):421.
25.
WangSChenSWCaiSLJinBY.A case report of retroperitoneal pararenal Castleman’s disease associated with myasthenia gravis. World J Surg Oncol. 2014;12:331.
KojimaMShimizuKKanekoYMasawaNNakamuraN.Lymphoid hyperplasia of the thymus showing Castleman’s disease in a patient with myasthenia gravis. Rheumatol Int. 2012;32(11):3695-3697.
28.
ChorzelskiaTHashimotocTMaciejewskabBAmagaidMAnhalteGJJablonskaaS.Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans. J Am Acad Dermatol. 1999;41(3):393-400.
